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Case Number 6
Pancreatic Ductal Adenocarcinoma
Daniel Debattista & Sarah Bezzina
Reviewed by: Mr N. Spiteri & Mr A. Attard
Case summary:
Demographic details:
Mr. SS, male, Tarxien
Referred from: Polyclinic
A 61-year-old gentleman who lives with his wife and 20-year-old son, presented to the polyclinic with 
a four week history of pruritus. On examination he was found to be jaundiced and his LFTs were high. 
Consequently he was referred to Mater Dei Hospital where, following ERCP and MRCP, he was found to 
have a tumour of the head of the pancreas, causing a stricture of the common bile duct, with consequent 
obstructive jaundice. The patient was planned for Whipple’s operation (pancreatico-duodenectomy), 
which was extended to total pancreatectomy, splenectomy and cholecystectomy. The operation was 
successful and the patient is recovering. 
Presenting complaint:
Pruritus: 4 weeks
History of presenting complaint:
The patient reported generalised itching for four weeks. The itching woke him up at night and disturbed 
his sleep. The patient was jaundiced and reported passing dark urine and pale stools which were difficult 
to flush. Recent weight loss and decreased appetite were also reported. The patient denied any back pain 
or abdominal pain. Moreover, he did not experience any chills or rigors. He reported reflux and dyspepsia 
following a meal. He did not complain of any nausea, vomiting or haematemesis.
Past medical and surgical history:
Past medical history:
• Hypertension
• No history of diabetes, ischaemic heart disease, asthma, chronic heart failure or epilepsy.
• No previous history of jaundice.
Drug history:1
Drug Dosage Frequency Type Reason
Amlodipine 5mg PO Dly Calcium Channel Blocker Hypertension
Enalapril 20mg PO Dly ACE-Inhibitor Hypertension
Burinex 2mg PO Dly Loop Diuretic Hypertension
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Family history:
Father died of a myocardial infarction at the age of 66. 
Mother died of pulmonary embolism.
Siblings and children do not suffer from any medical condition.
No family history of cancer.
Social history:
The patient is a married pensioner, father of three, who lives with his wife and youngest son. He used to 
do clerical work. He is a non-smoker and drinks socially. He does not abuse of drugs.
Systemic inquiry: 
• General Health: looks well in general; reported recent weight loss and decreased appetite
• Cardiovascular System: nil to note
• Respiratory System: nil to note
• Gastrointestinal System: GORD and bloating after a meal; pale stools which are difficult to flush
• Genitourinary System: dark urine (though occasionally it is clear)
• Central Nervous System: nil to note
• Musculoskeletal System: nil to note
• Endocrine System: nil to note
Pre-operative therapy:
• Vitamin K supplements (10mg/Dly, IV) were given in view of the fact that the coagulation cascade 
may be deficient in such patients1.
• Prophylactic Clexane® (enoxaparin) therapy was given pre-operatively in view of increased risk 
of deep vein thrombosis in patients undergoing surgery1.
• Phenergan® (promethazine hydrochloride) was given for symptomatic treatment of pruritus1.
Discussion of results of general and specific examinations:
Feature Discussion
Jaundice, pruritus, pale stools and 
dark urine
Indicative of an obstructive lesion in the biliary tree. The 
conjugated hyperbilirubinaemia causes the itchiness in the 
skin and yellow discolouration in the skin and sclera. Since no 
bile is secreted from the common bile duct, the stools are pale. 
Conjugated hyperbilirubinaemia is water soluble and thus is 
excreted in greater amounts in the urine, turning it dark. 
Steatorrhoea Indicates that lipid absorption is impaired because of an 
obstruction to the biliary tree, thus inhibiting pancreatic 
enzymes (including lipase) from being secreted into the small 
intestine. Lipids are not digested and are passed with the stool, 
making it difficult to flush.
Weight loss and anorexia May indicate a chronic illness such as a tumour.
No abdominal pain Shows that the condition is unlikely to be inflammatory.
Soft abdomen Excludes peritonitis.
No chills or rigors Absence of pyrexia makes infective cause unlikely.
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Differential diagnosis:3,4   
Differential diagnosis is from other causes of painless obstructive jaundice3, such as:
Differential Diagnosis Features
Tumour of the head of pancreas, 
periampullary malignant tumours
Biliary ducts appear dilated on ultrasound. This is 
characterised by painless jaundice, weight loss, and 
obstruction within head of pancreas, which is confirmed 
via ERCP and MRCP.
Common bile duct stones Characterised by tenderness in the right upper quadrant, 
and dilatation of biliary ducts on ultrasound. However, 
abdominal pain may be absent.
Benign strictures of the common bile duct May be due to surgical damage or inflammation caused 
by a previous stone. Obstructive features are similar to 
carcinoma of the head of pancreas.
Intrahepatic cholestasis Mainly caused by viral hepatitis. Low grade jaundice is 
due to systemic sepsis.
Primary biliary cirrhosis Hepatomegaly and possible splenomegaly, xanthomas and 
arthralgia. This disease is characterised by a positive test 
for anti-mitochondrial antibody and serum IgM. Cirrhosis 
is confirmed via liver biopsy.
Drugs, such as phenothiazines, anabolic 
steroids and erythromycin
Discontinuing such drugs will relieve symptoms of 
obstructive jaundice.
Alcoholic hepatitis A history of excessive alcohol intake is needed. Presents 
with features of chronic liver disease, such as spider 
naevi.
Sclerosing cholangitis Presence of beading in intra- and extra-hepatic bile ducts 
on ERCP
Dubin-Johnson syndrome Characterised by decreased excretion of conjugated 
bilirubin, intermittent jaundice and pain in the right 
hypochondrium. Increased urinary bilirubin and pigment 
granules on liver biopsy.
Diagnostic procedures:
Instrumental exams:
Test: Ultrasound Abdomen (Figure 1)
Justification for test: Patient with pruritus and abnormal LFTs; suspecting stone in biliary tree 
Result: Dilated biliary tree and pancreatic duct
Conclusion: Further investigation recommended – referred for CT scan
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Figure 1: Ultrasound Image, showing the dilated (0.8cm) common bile duct (arrow)
Test: CT Abdomen (Figure 2)
Justification for test: Patient with painless jaundice and dark urine; post ultrasound abdomen findings, 
                                  suspecting gall stone
Result: Pancreatic duct dilatation and evidence of distal biliary obstruction; no calculi or significant mass 
            lesion
Conclusion: Suspecting vater papilla process and ampullary tumour; ERCP recommended
 
 
Figure 2: Preoperative CT Abdomen - showing the dilated pancreatic duct (arrow)
Test: ERCP (Endoscopic Rertrograde Cholangiopancreatography) (Figure 3)
Justification for test: To rule out pancreatic head pathology
Result: Ampulla appeared flat and normal; suspected common bile duct stricture
Conclusion: Result inconclusive – patient referred for MRCP
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Figure 3: ERCP, showing the biliary tree
Test: MRCP (Magnetic Resonance Cholangiopancreatography) (Figure 4)
Justification for test: Confirm ERCP findings
Result: Common bile duct stricture, noted to be possibly malignant
Conclusion: Suspicion of obstruction of the common bile duct within the head of pancreas confirmed.
                    Surgery needed to resect pancreatic head pathology
 
 
Figure 4: MRCP showing stricture at common bile duct (arrow), with proximal dilatation
Therapy:
Drugs:1
 
Drug Dosage Frequency Type Reason
Promethazine 
Hydrochloride 
(Phenergan®)
50mg PO TDS Antihistamine Symptomatic relief 
treatment of pruritus
Bumetanide 1mg PO Dly Loop Diuretic Hypertension
44
Enalapril 20mg PO Dly ACE-Inhibitor Hypertension
Amlodipine 5mg PO Dly Calcium Channel 
Blocker
Hypertension
Vitamin K 10mg IV Dly Vitamin 
supplements
Aids the clotting cascade as 
this may be deficient in such 
patients
Enoxaparin 
Sodium
(Clexane®)  
40mg SC Dly Parenteral 
angicoagulant
Prophylaxis of deep-vein 
thrombosis in surgical pa-
tients
Actrapid Continuous Infusion 
according to blood 
glucose level
Continuous 
Infusion 
according 
to blood 
glucose 
level
Soluble Insulin Insulin deficiency due to 
pancreatectomy
Cefuroxime 
(Zinacef®)
750mg IV TDS Cephalosporin Prophylaxis post-
splenectomy and post-
laparotomy
Metronidazole 500mg IV TDS Antimicrobial Post distal gastrectomy and 
roux-en-Y anastomosis
Paracetamol 1g PO 6hrly Analgesic Pain Relief
Octreotide 25mcg infusion Hrly Somatostatic 
analogue
Prevent complications of 
pancreatic surgery
 
Surgical therapy:  
 
Pre-operative: Admitted two days early due to episode of vomiting. Was given IVI N saline and 10cc 
20% KCl 1L 8-hourly, in order to compensate for fluid loss and low sodium concentration in the blood. 
In addition, promethazine hydrochloride was given. All hypertensive drugs were continued, except for 
burinex. On the day prior to surgery, the patient started fasting, BP was monitored and bloods were sent 
for crossmatch. 
Operation:  A total pancreatectomy, duodenectomy, splenectomy, cholecystectomy, distal gastrectomy 
and roux-en-Y anastomosis were performed. On operating, a tumour of the head of pancreas was 
identified. There was no evidence of metastasis. 
The duodenum was mobilised and the common bile duct, the common hepatic duct and the portal vein 
were dissected. An enlarged lymph node was found at the porta hepatis and sent to frozen section. 
Fortunately this was found to be benign. The gall bladder was dissected fundus first and the cystic artery 
was divided using sutures.
The neck of the pancreas was dissected off the portal vein and divided. The common bile duct was 
divided and the biliary stent removed. The duodeno-jejunal flexure was mobilised and divided. The head 
of pancreas was removed together with the duodenum, gall bladder and distal third of the stomach.
Completion of pancreatectomy and splenectomy were performed. Roux-en-Y anastomosis was performed 
using a loop of jejunum. Choledochojejunostomy (anastomosis between common bile duct and jejunum) 
was performed using stapling device. Jejuno-jejunostomy was performed using side to side anastomosis 
with stapling device. Mesenteric defects were then closed, a drain was inserted and the wound was closed.
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The following specimens were sent to histology:
• Head of pancreas and distal stomach
• Distal pancreas and spleen
• Gall bladder 
Post-operation: The patient was transferred to ITU and was administered the drug treatment listed in the 
table above. IVI and analgesia were given as required. In view of total pancreatectomy, the patient was 
to be given continuous actrapid infusion even if glucose levels were to be normal initially. Vaccines were 
planned post-splenectomy – these include prophylactic immunisation with pneumococcal, meningococcal 
and H. influenza type B vaccines2. In addition, cefuroxime (prophylaxis active against haemophilus 
influenzae) was given post-splenectomy. Metronidazole (effective Helicobacter pylori eradication) was 
given in view of partial gastrectomy and roux-en-Y anastomosis.
Laboratory findings postoperatively:
• A frozen section taken from a possible metastatic lesion was found to be benign.
• Mild fibrous cholecystitis was found at the fundus of the gall bladder.
• No evidence of tumour infiltration at the pancreatic tail.
• Spleen and splenic hilum were found to be normal.
• A well differentiated invasive pancreatic ductal carcinoma was found at the head of pancreas 
and encroaching the ampulla. The invasive tumour was associated with widespread pancreatic 
intraepithelial neoplasia and intraductal carcinoma. Extensive perineural and lymphovascular 
invasion was found. Foci of intraductal carcinoma extend to less than 1mm from both the superior 
mesenteric vessel margin and the posterior margin. The anterior margin is clear of tumour.
• Three out of eleven regional pancreatic lymph nodes show metastatic adenocarcinoma. Two greater 
curve lymph nodes were sampled and were found to be free of tumour. A single focus of malignant 
cells was found at the perineurum of a large nerve.
 
 
Figure 5:  Post op CT Abdomen, showing extensive ascites in the subhepatic region (arrow)
Diagnosis:
Based on laboratory findings from specimen of excised organs, the following diagnosis was elicited:
Grade 1 pancreatic ductal adenocarcinoma. The tumour at the pancreatic duct traversing the head of 
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pancreas resulted in compression of the common bile duct, with consequent features of obstructive 
jaundice. Pancreatic cancer is renowned for its rapid progression and poor prognosis. Often treatment is 
palliative due to extensive metastasis. However, in rare cases such as this one, early presentation with the 
lesion confined to the head of the pancreas, curative surgical resection is possible.
Final treatment and follow ups:
In the days that followed the operation, the patient passed altered blood PR (malaena), experienced nausea 
and brought up coffee ground vomit. These were managed by administering omeprazole (proton pump 
inhibitor) and ranitidine (H2-receptor blocker); and antiemetic therapy - metoclopramide hydrochloride 
(maxolon®). In addition, an OGD was performed, with findings of slight erythema, without active 
bleeding in the body of the stomach and normal post-operative appearance of the gastro-jejunostomy, 
without any signs of bleeding.
A diabetologist was consulted in order to manage the insulin regimen.
A CT scan of the thorax, abdomen and pelvis was performed  9 days post-operatively in order to investigate 
confusion post-total pancreatectomy. Findings included extensive bilateral pleural effusion, atelectatic 
changes in the lower lobes of the lungs and extensive ascites, mainly in the subhepatic region (Figure 5). 
However, no lymphadenopathy was noted and the liver was homogenous in structure.
Furthermore, a CT scan of the brain was carried out, in which no focal lesions were found and midline 
structures were not displaced.
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Fact Box 6:
Title: Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma is a highly malignant tumour which arises from the cells lining the 
pancreatic duct. It is the fifth commonest tumour worldwide. It has a high mortality and is often diagnosed 
late.
Risk factors:
• Family history of tumour 
• Smoking
Signs and Symptoms: 
• Jaundice
• Dull epigastric pain which may radiate to the back 
• Itching 
• Recent onset diabetes 
• Thrombophlebitis
• Migraines
• Anorexia
• Weight loss
Treatment: In most cases this is palliative, either via a surgical bypass or insertion of a stent through the 
common bile duct. A curable surgical resection involves Whipple’s pancreaticoduodenectomy.
Prognosis: Poor, most cases are not operable. In the case of those which are operable, surgery is associated 
with a high mortality and few survive for more than 5 years.
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